Novo Nordisk A/S technical analysis
Technical analysis of Novo Nordisk A/S (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Novo Nordisk A/S
Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 that researches, develops, manufactures and distributes pharmaceutical products. The company primarily operates in the obesity and diabetes care segment, as well as in rare diseases, offering therapies for diabetes, obesity, cardiovascular conditions and rare blood disorders. Its products include smart insulin pens, dose guidance applications and GLP-1 receptor agonist therapies, distributed across Europe, North America, Asia, Oceania and other geographic regions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Novo Nordisk A/S: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
46.36 $
+0.52%
50 sessions
47.46 $
−1.81%
200 sessions
45.06 $
+3.43%
Session levels
s2
45.93
Support
s1
46.72
Support
pivot
47.36
Pivot
r1
48.15
Resistance
r2
48.79
Resistance
How to read it
In the September 4, 2026 session Novo Nordisk A/S closed lower at 46.60 $, −1.92% versus the previous session.
The price sits mixed against its moving averages: +0.52% against the 21-session average, −1.81% against the 50 and +3.43% against the 200.
The 14-period RSI reads 50.0, in neutral territory.
MACD stands at -0.116 against a signal line at -0.203: the histogram is positive (+0.087).
ADX reads 12.0, indicating weak directionality.
Levels computed on the latest session place supports at 46.72 and 45.93 $ and resistances at 48.15 and 48.79 $, around a pivot of 47.36.
The average daily range (ATR) is 1.357 $, or 2.91% of price.
Turnover was 6.2M shares, 60% of the 20-session average.
Over the last twelve months the price ranged between 34.18 and 51.46 $, and today stands −9.44% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the NVO analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Novo Nordisk A/S
How is Novo Nordisk A/S analysed technically?
Technical analysis of Novo Nordisk A/S is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Novo Nordisk A/S?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Novo Nordisk A/S?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Novo Nordisk A/S it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.